SENNA LAXATIVE- sennosides 8.6 mg tablet 
NUVICARE LLC

----------

Active Ingredient

Sennosides 8.6 mg

Purpose

Laxative

Uses:

Warnings:

Do not use

Ask a doctor before use if you have

Stop use and ask a doctor if you have:

If pregnant or breast-feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. 

DIRECTIONS

age

starting dosage

maximum dosage

adults & children 12 years of age and over

2 tablets once a day

4 tablets twice a day

children 6 to under 12 years

1 tablet once a day

2 tablets twice a day

children 2 to under 6 years

1 /2 tablet once a day

1 tablet twice a day

children under 2 years

ask a doctor

ask a doctor

OTHER INFORMATION

INACTIVE INGREDIENTS

Colloidal silicon dioxide,croscarmellose sodium, Dicalcium phosphate, Hypromellose, liquid paraffin, magnesium stearate, microcrystalline cellulose, Maltodextrin, Purified water, Sodium lauryl sulphate, Stearic Acid.

QUESTIONS OR COMMENTS?

Call 1 (718) 337-8733 or visit: support@nuvicare.com

PL0211-00 NC-Senna Natural-Senokot-200ct

SENNA LAXATIVE 
sennosides 8.6 mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84324-012
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID D7 (UNII: T3B081197X)  
PARAFFIN (UNII: I9O0E3H2ZE)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize10mm
FlavorImprint Code none
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:84324-012-01200 in 1 BOTTLE; Type 0: Not a Combination Product07/17/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)07/17/2024
Labeler - NUVICARE LLC (119257565)
Registrant - NUVICARE LLC (119257565)

Revised: 7/2024
Document Id: 4f3b29ee-3a8d-41db-8afa-4607b46772de
Set id: 372e8b67-2b9a-4416-b6c2-f44fd24f35e9
Version: 1
Effective Time: 20240717
 
NUVICARE LLC